KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Zimmer Biomet Holdings (ZBH) Interest Expenses (2016 - 2018)

Historic Interest Expenses for Zimmer Biomet Holdings (ZBH) over the last 8 years, with Q3 2018 value amounting to $68.3 million.

  • Zimmer Biomet Holdings' Interest Expenses fell 1701.09% to $68.3 million in Q3 2018 from the same period last year, while for Jun 2019 it was $68.3 million, marking a year-over-year decrease of 7846.11%. This contributed to the annual value of $327.5 million for FY2017, which is 849.4% down from last year.
  • Per Zimmer Biomet Holdings' latest filing, its Interest Expenses stood at $68.3 million for Q3 2018, which was down 1701.09% from $75.9 million recorded in Q2 2018.
  • In the past 5 years, Zimmer Biomet Holdings' Interest Expenses ranged from a high of $91.5 million in Q3 2016 and a low of $15.0 million during Q1 2014
  • Moreover, its 5-year median value for Interest Expenses was $82.3 million (2017), whereas its average is $66.2 million.
  • In the last 5 years, Zimmer Biomet Holdings' Interest Expenses plummeted by 1758.24% in 2014 and then skyrocketed by 46250.0% in 2015.
  • Over the past 5 years, Zimmer Biomet Holdings' Interest Expenses (Quarter) stood at $16.0 million in 2014, then soared by 462.5% to $90.0 million in 2015, then rose by 0.11% to $90.1 million in 2016, then fell by 11.21% to $80.0 million in 2017, then dropped by 14.62% to $68.3 million in 2018.
  • Its Interest Expenses stands at $68.3 million for Q3 2018, versus $75.9 million for Q2 2018 and $78.9 million for Q1 2018.